Microvascular Structural Alterations in Cancer Patients Treated With Antiangiogenic Drugs

Objective: Antiangiogenic therapies (tyrosine kinase inhibitors-TKI and direct anti-VEGF monoclonal antibodies) are being increasingly used in the treatment of solid tumors; hypertension represents a common side effect of these agents. Several mechanisms are involved in the development of hypertensi...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Front Cardiovasc Med
Main Authors: Coschignano, Maria Antonietta, De Ciuceis, Carolina, Agabiti-Rosei, Claudia, Brami, Valeria, Rossini, Claudia, Chiarini, Giulia, Malerba, Paolo, Famà, Francesca, Cosentini, Deborah, Muiesan, Maria Lorenza, Salvetti, Massimo, Petelca, Alina, Capellini, Sara, Arnoldi, Chiara, Nardin, Matteo, Grisanti, Salvatore, Rizzoni, Damiano, Berruti, Alfredo, Paini, Anna
פורמט: Artigo
שפה:Inglês
יצא לאור: Frontiers Media S.A. 2021
נושאים:
Cardiovascular Medicine
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7987651/
https://ncbi.nlm.nih.gov/pubmed/33778028
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcvm.2021.651594
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים